C4 Therapeutics, Inc. · NASDAQ:CCCC

Morgan Stanley reported a 5.40% stake in C4 Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 3, 2025

Morgan Stanley reported a 5.40% stake in C4 Therapeutics, Inc., 3,828,810 shares, as a passive investor on Dec 31, 2024. Filed Feb 3, 2025 (Schedule 13G).

Stake
5.40%
Shares
3,828,810
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Morgan Stanley5.40%3,828,810

Source

View original at SEC

Related